13.63
price down icon0.18%   -0.025
after-market Dopo l'orario di chiusura: 13.64 0.005 +0.04%
loading
Precedente Chiudi:
$13.66
Aprire:
$13.81
Volume 24 ore:
222.06K
Relative Volume:
0.79
Capitalizzazione di mercato:
$455.68M
Reddito:
-
Utile/perdita netta:
$-47.20M
Rapporto P/E:
-8.7108
EPS:
-1.5653
Flusso di cassa netto:
$-43.65M
1 W Prestazione:
+8.91%
1M Prestazione:
+13.62%
6M Prestazione:
-29.13%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$13.56
$14.34
Intervallo di 1 settimana:
Value
$12.20
$14.34
Portata 52W:
Value
$4.8069
$27.50

Mbx Biosciences Inc Stock (MBX) Company Profile

Name
Nome
Mbx Biosciences Inc
Name
Telefono
(317) 989-3100
Name
Indirizzo
11711 N. MERIDIAN STREET, CARMEL
Name
Dipendente
43
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
MBX's Discussions on Twitter

Confronta MBX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MBX
Mbx Biosciences Inc
13.63 418.47M 0 -47.20M -43.65M -1.5653
Biotechnology icon
ONC
Beone Medicines Ltd Adr
258.27 26.01B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.85 114.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.3499 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
83.98 6.29B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
484.93 63.90B 14.09B 4.50B 2.96B 39.28

Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-10 Iniziato Citizens JMP Mkt Outperform
2024-10-08 Iniziato Guggenheim Buy
2024-10-08 Iniziato JP Morgan Overweight
2024-10-08 Iniziato Jefferies Buy
2024-10-08 Iniziato Stifel Buy

Mbx Biosciences Inc Borsa (MBX) Ultime notizie

pulisher
Jun 04, 2025

Deutsche Bank AG Buys New Position in MBX Biosciences, Inc. (NYSE:MBX) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases Shares of 6,335 MBX Biosciences, Inc. (NYSE:MBX) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

MBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative Buy - Seeking Alpha

May 31, 2025
pulisher
May 30, 2025

MBX Biosciences, Inc. (NYSE:MBX) Given Consensus Rating of “Buy” by Brokerages - Defense World

May 30, 2025
pulisher
May 28, 2025

MBX Biosciences, Inc. (NYSE:MBX) Shares Sold by Millennium Management LLC - Defense World

May 28, 2025
pulisher
May 27, 2025

Northern Trust Corp Invests $1.67 Million in MBX Biosciences, Inc. (NYSE:MBX) - Defense World

May 27, 2025
pulisher
May 20, 2025

MBX Biosciences to Participate in June Investor Conferences - GlobeNewswire

May 20, 2025
pulisher
May 20, 2025

MBX Biosciences Showcases Precision Peptide Pipeline at Two Major Healthcare Conferences This June - Stock Titan

May 20, 2025
pulisher
May 19, 2025

Citadel Advisors LLC Grows Stock Holdings in MBX Biosciences, Inc. (NYSE:MBX) - Defense World

May 19, 2025
pulisher
May 15, 2025

MBX Biosciences, Inc. (NYSE:MBX) Shares Acquired by The Manufacturers Life Insurance Company - Defense World

May 15, 2025
pulisher
May 14, 2025

MBX Biosciences Reports Q1 2025 Financial Progress - TipRanks

May 14, 2025
pulisher
May 13, 2025

MBX Biosciences, Inc.: Strong Buy Rating Amid Promising Phase II Data and Robust Financial Position - TipRanks

May 13, 2025
pulisher
May 12, 2025

Stifel maintains MBX Biosciences stock Buy rating, $40 target By Investing.com - Investing.com Nigeria

May 12, 2025
pulisher
May 12, 2025

Stifel maintains MBX Biosciences stock Buy rating, $40 target - Investing.com

May 12, 2025
pulisher
May 12, 2025

MBX Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times

May 12, 2025
pulisher
May 12, 2025

Wells Fargo & Company MN Purchases Shares of 5,844 MBX Biosciences, Inc. (NYSE:MBX) - Defense World

May 12, 2025
pulisher
May 09, 2025

Hypoglycemia Market Poised for Notable Growth by 2032, Fueled - openPR.com

May 09, 2025
pulisher
May 05, 2025

MBX Biosciences Up 28%, Insider Buyers Are Up 19% - simplywall.st

May 05, 2025
pulisher
May 05, 2025

MBX Biosciences, Inc. (NYSE:MBX) Receives Consensus Rating of “Buy” from Analysts - Defense World

May 05, 2025
pulisher
Apr 27, 2025

MBX Biosciences, Inc. (NYSE:MBX) Shares Purchased by Geode Capital Management LLC - Defense World

Apr 27, 2025
pulisher
Apr 23, 2025

JMP maintains MBX Biosciences stock $38 target, upbeat on trial data - Investing.com Australia

Apr 23, 2025
pulisher
Apr 23, 2025

Companies Like MBX Biosciences (NASDAQ:MBX) Are In A Position To Invest In Growth - Yahoo Finance

Apr 23, 2025
pulisher
Apr 22, 2025

MBX Biosciences to Participate in Citizens and RBC May Investor Conferences - The Manila Times

Apr 22, 2025
pulisher
Apr 22, 2025

MBX Biosciences Reveals Growth Strategy at Citizens and RBC Healthcare Conferences: Key Updates Coming - Stock Titan

Apr 22, 2025
pulisher
Apr 16, 2025

5,593 Shares in MBX Biosciences, Inc. (NYSE:MBX) Acquired by Corebridge Financial Inc. - Defense World

Apr 16, 2025
pulisher
Apr 13, 2025

25,000 Shares in MBX Biosciences, Inc. (NYSE:MBX) Acquired by Norges Bank - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

MBX Biosciences, Inc. (NYSE:MBX) Receives $37.40 Consensus Price Target from Brokerages - Defense World

Apr 13, 2025
pulisher
Apr 11, 2025

MBX Biosciences initiated at Market Outperform by Citizens - MSN

Apr 11, 2025
pulisher
Apr 10, 2025

Director Makes Bold Move with Major MBX Biosciences Stock Purchase - TipRanks

Apr 10, 2025
pulisher
Apr 10, 2025

JMP Securities Initiates Coverage of MBX Biosciences (MBX) with Market Outperform Recommendation - Nasdaq

Apr 10, 2025
pulisher
Apr 10, 2025

MBX Biosciences: Innovative PEP Platform and Promising Pipeline Drive Buy Rating - TipRanks

Apr 10, 2025
pulisher
Apr 10, 2025

MBX Bio stock initiated at Market Outperform by Citizens (MBX) - Seeking Alpha

Apr 10, 2025
pulisher
Apr 10, 2025

MBX Biosciences director Pescovitz buys $45,311 in stock By Investing.com - Investing.com Canada

Apr 10, 2025
pulisher
Apr 10, 2025

MBX Biosciences director Pescovitz buys $45,311 in stock - Investing.com

Apr 10, 2025
pulisher
Apr 10, 2025

MBX Biosciences initiated with an Outperform at Citizens JMP - TipRanks

Apr 10, 2025
pulisher
Apr 07, 2025

MBX Biosciences adds biotech veteran to board By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

MBX Biosciences adds biotech veteran to board - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

MBX Biosciences Appoints Steve Hoerter to Board - TipRanks

Apr 07, 2025
pulisher
Apr 07, 2025

MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors - GlobeNewswire

Apr 07, 2025
pulisher
Mar 30, 2025

Charles Schwab Investment Management Inc. Invests $1.72 Million in MBX Biosciences, Inc. (NYSE:MBX) - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

Bank of New York Mellon Corp Buys Shares of 23,914 MBX Biosciences, Inc. (NYSE:MBX) - Defense World

Mar 28, 2025
pulisher
Mar 26, 2025

MBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Mar 26, 2025
pulisher
Mar 26, 2025

MBX Biosciences Unveils Next-Gen Peptide Therapies: CEO Presentation at Major Healthcare Conference - Stock Titan

Mar 26, 2025
pulisher
Mar 19, 2025

MBX Biosciences Inc Reports Q4 2024 Net Loss of $15.6 Million, S - GuruFocus

Mar 19, 2025

Mbx Biosciences Inc Azioni (MBX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.16
price up icon 0.00%
$573.50
price down icon 0.54%
$36.08
price up icon 15.90%
$305.31
price up icon 0.51%
$4.75
price up icon 3.70%
$484.93
price down icon 0.60%
Capitalizzazione:     |  Volume (24 ore):